CVS Health Corp.

CVS Health is projecting mid-teens adjusted EPS CAGR through 2028, raised 2025 guidance across all metrics, and initiated 2026 guidance showing continued earnings acceleration. Aetna margin recovery and pharmacy-as-front-door strategy are the key drivers.